期刊文献+

华蟾素注射液对与人肝癌HepG-2细胞共培养下人淋巴管内皮细胞的增殖及管状结构形成的影响

Effect of Cinobufacini Injection on Proliferation and Tube-Like Structure Formation of Human Lymphatic Endothelial Cells Co-Cultured with Human Hepatoma HepG-2 Cells
原文传递
导出
摘要 目的探讨华蟾素注射液对与人肝癌HepG-2细胞共培养下人淋巴内皮细胞增殖、迁移及管状结构形成的影响。方法采用Transwell方法建立HepG-2细胞与人淋巴内皮细胞共培养系统;通过绘制细胞生长曲线,观察华蟾素注射液对共培养系统中人淋巴内皮细胞增殖的影响;通过细胞迁移实验,观察华蟾素注射液对共培养系统中人淋巴内皮细胞迁移的影响;通过基质胶实验,观察华蟾素注射液对共培养系统中人淋巴内皮细胞管状结构形成的影响。结果华蟾素注射液能够显著抑制与HepG-2细胞共培养下人淋巴内皮细胞增殖(P<0.05),迁移(P<0.05)及管状结构形成(P<0.05),呈剂量依赖性。结论华蟾素注射液抑制与HepG-2细胞共培养下人淋巴内皮细胞增殖,迁移及管状结构形成,可能是华蟾素注射液抑制肿瘤淋巴道转移的机制之一。 OBJECTIVE To study the effect of cinobufacini injection on proliferation, migration and tube-like structure formation of human hepatoma HepG-2 cells co-cultured with human lymphatic endothelial cells. METHODS Co-culture system of human hepa- toma HepG-2 cells and human lymphatic endothelial cells is established by means of transwell chamber; cell growth curve is used to ob- serve the effect of cinobufacini injection on the proliferation of HLEC co-cuhured with HepG-2 cells ; migration assay is used to observe the effect of cinobufacini injection on the migration of HLEC co-cultured with HepG-2 ; matrigel assay is used to observe the effect of cinobufacini injection on the tube-like structure formation of HLEC co-cultured with HepG-2 cells. RESULTS Cinobufacini injection significantly inhibits proliferation( P 〈 0. 05 ), migration ( P 〈 0. 05 ) and tube-like structure formation ( P 〈 0. 05 ) of HLEC co-cultured with HepG-2 cells in dose dependent ways. CONCLUSION Cinobufacini injection inhibits proliferation, migration and tube-like structure formation of HLEC co-cultured with HepG-2 cells ,which might contribute the inhibiting mechanisms of cinobufacini injection on tumor metastasis.
出处 《中国药学杂志》 CAS CSCD 北大核心 2013年第21期1837-1840,共4页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(81173615)
关键词 华蟾素注射液 HEPG-2细胞 人淋巴内皮细胞 增殖 迁移 管状结构形成 einobufacini injection HepG-2 cell HLEC proliferation migration tube-like structure formation
  • 相关文献

参考文献2

二级参考文献11

  • 1朱晓燕(综述),刘鲁明(审校).华蟾素注射液及其活性成份抗肿瘤机制的研究进展[J].世界肿瘤杂志,2006,5(4):272-275. 被引量:20
  • 2陈卫华,陈燕,崔国惠.鱼藤素作用K562细胞TopoⅠ表达的探讨[J].中国肿瘤临床,2007,34(3):121-124. 被引量:3
  • 3Song IH.Molecular targeting for treatment of advanced hepatocellular carcinoma[J].Korean J Hepatol,2009,15(3):299-308.
  • 4Liu LF.DNA tupoisomerase poisons as antitumor drugs[J].Annu Rev Biochem,1989,58:351-375.
  • 5Giovanella BC,Stehlin JS,Wall ME,et al.DNA topoisomerase Ⅰ-targeted chemotherapy of human colon cancer in xenografts[J].Science,1989,246(4933):1046-1048.
  • 6Potmesil M,Hsiang YH,Liu LF,et al.Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase Ⅱ[J].Cancer Res,1988,48:3537-3543.
  • 7Rho YH,Lee BW,Park KH,et al.Cudraflavanone A purified from Cudrania tricuspidata induces apoptotic cell death of human leukemia U937 cells,at least in part,through the inhibition of DNA topoisomerase Ⅰ and protein kinase C activity[J].Anti-Cancer Drugs,2007,18(9):1023-1028.
  • 8Sano K,Shuhin T.A study of topoisomerase activity in human tcsticular cancers[J].Anticancer Res,1995,15(5B):2117-2120.
  • 9蒙凌华,蒋超,刘兆乾,齐清,丁健.螺旋藻提取物对DNA拓扑异构酶活性的抑制及对DNA的直接影响[J].癌症,2000,19(8):768-771. 被引量:57
  • 10苏永华,黄雪强,张大志,张亚妮,谢觉民,凌昌全.华蟾素注射液中蟾毒内酯类成分含量检测[J].中成药,2003,25(1):24-27. 被引量:49

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部